Half Year Results 

Oxford Biodynamics expanding its clinical reach

Oxford Biodynamics expanding its clinical reach

Post period-end, Oxford BioDynamics (OPD) picked up the Queen’s Award for Enterprise: Innovation, but acknowledgement from the Head of State will only get you so far. You get a better idea of where the biomarker developer might be headed through the collaborative agreements undertaken during the period.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now